The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-N-(2-methoxyethyl)-1-((R)-1-(pyridine-2-yl)ethyl)-1H-imidazo[4,5-c]quinoline-2-amine ID: ALA4874801
PubChem CID: 66571469
Max Phase: Preclinical
Molecular Formula: C26H28N6O3
Molecular Weight: 472.55
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COCCNc1nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c2n1[C@H](C)c1ccccn1
Standard InChI: InChI=1S/C26H28N6O3/c1-15-24(17(3)35-31-15)19-12-21-18(13-23(19)34-5)25-22(14-29-21)30-26(28-10-11-33-4)32(25)16(2)20-8-6-7-9-27-20/h6-9,12-14,16H,10-11H2,1-5H3,(H,28,30)/t16-/m1/s1
Standard InChI Key: VNTLEGVQLWKYEU-MRXNPFEDSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
15.5364 -26.4839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5353 -27.3114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2501 -27.7242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2483 -26.0712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9637 -26.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9645 -27.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6798 -27.7182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3949 -27.3034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6742 -26.0662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3868 -26.4745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9953 -25.9229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6588 -25.1737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8423 -25.2623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2882 -24.6510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8219 -26.0716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8217 -25.2466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8205 -27.7233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0698 -27.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5173 -28.0032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9292 -28.7180 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7363 -28.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8979 -26.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3500 -29.0984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5406 -23.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3467 -23.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5991 -22.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0448 -22.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2348 -22.4777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9861 -23.2622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0689 -24.4578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8939 -24.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4818 -24.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3087 -25.1681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1338 -25.1653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5487 -25.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 10 1 0
9 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
13 14 1 0
1 15 1 0
15 16 1 0
2 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 17 2 0
18 22 1 0
21 23 1 0
14 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
12 30 1 0
30 31 1 0
14 32 1 6
31 33 1 0
33 34 1 0
34 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.55Molecular Weight (Monoisotopic): 472.2223AlogP: 4.93#Rotatable Bonds: 8Polar Surface Area: 100.12Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.78CX LogP: 3.09CX LogD: 3.09Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.32Np Likeness Score: -1.18
References 1. Jones KL, Beaumont DM, Bernard SG, Bit RA, Campbell SP, Chung CW, Cutler L, Demont EH, Dennis K, Gordon L, Gray JR, Haase MV, Lewis AJ, McCleary S, Mitchell DJ, Moore SM, Parr N, Robb OJ, Smithers N, Soden PE, Suckling CJ, Taylor S, Walker AL, Watson RJ, Prinjha RK.. (2021) Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression., 64 (16.0): [PMID:34387088 ] [10.1021/acs.jmedchem.1c00855 ]